Chapter

Angst und Neurose

Authors:
To read the full-text of this research, you can request a copy directly from the author.

Abstract

Daß der 1895 von Freud ausführlich beschriebene Symptomkomplex der Angstneurose nicht nur in der biologischen Psychiatrie, sondern auch in der Psychoanalyse und psychodynamischen Psychotherapie derzeit wieder mehr Beachtung findet, resultiert u.a. aus verschiedenen aktuellen Entwicklungen wie 1 den neueren Verständnisansätzen zur Psychogenese und Psychodynamik von Angstneurosen, einschließlich der Paar- und Familiendynamik, 2 den Weiterentwicklungen der psychoanalytischen Behandlungstechniken bei schwer und früh gestörten Patienten, 3 der durch Einführung der DSM-III-Klassifikation und der strukturierten klinischen Interviews in Gang gekommenen Diskussion über diagnostische Prozesse, 4 der Entwicklung von spezifischen Kurzpsychotherapieverfahren mit der Erarbeitung von Manualen und Trainingsprogrammen und 5 den neueren Ergebnissen kontrollierter Studien zur Kombination von Psychotherapie und Pharmakotherapie.

No full-text available

Request Full-text Paper PDF

To read the full-text of this research,
you can request a copy directly from the author.

ResearchGate has not been able to resolve any citations for this publication.
Chapter
„Letzte Nacht hatte ich einen seltsamen Traum. Ich fuhr auf einer verlassenen Wegstrecke. Um mich streckte sich die Wüste. — Ich überholte ein Mädchen. Wir beide stoppten. Ich sprach mit ihr, und dann gingen wir zurück zu ihrem Haus. Es war unheimlich und wurde mehr und mehr teuflisch. Wir hatten Sex, und es wurde wilder und wilder, in überwältigender, verrückter Leidenschaft. Dann waren wir nicht mehr allein. Ich wurde von dem Mädchen und einem Mann festgehalten und konnte mich nicht mehr rühren. Mit Rasierklingen begannen sie in meine Hände und Arme hineinzuschneiden und das Blut fließen zu lassen. Sie prüften meine Schmerzschwelle. Es schmerzte nicht. Aber ich verwandelte mich in einen von ihnen: etwas nahm mich in seine Gewalt, etwas wie ein Vampir, der einem das Blut aussaugt, und wenn man von ihm gebissen wird, verwandelt man sich in ihn. Mit den Rasierklingen ließen sie mein Blut auslaufen, und ich verwandelte mich in diese Leute... — Wir haben die Freude an allem verloren. Wir jagen nach Erfolg, doch können wir uns nie entspannen, da wir uns immer sogleich schuldig fühlen. — Unser Gewissen -Ressentiment und Verzweiflung“ [51].1
Article
• In a controlled outcome study of phobias, 111 adult patients (69% women, 31% men) received a course of 26 weekly treatment sessions consisting of (1) behavior therapy and imipramine hydrochloride (2) behavior therapy and placebo, or (3) supportive psychotherapy and imipramine. Patients were classified as agoraphobic, mixed phobic, or simple phobic. The great majority of patients in all groups showed moderate to marked global improvement (70% to 86%, depending on rater). In agoraphobics and mixed phobics (both groups experiencing spontaneous panic attacks), imipramine was significantly superior to placebo. There was no difference between behavior therapy and supportive therapy, both resulting in high improvement rates (76% to 100%, depending on rater). In simple phobic patients, there was a high rate of improvement with all treatment regimens (72% to 93%, depending on rater), with no significant difference between imipramine and placebo or between behavior therapy and supportive therapy. Of 88 moderately to markedly improved patients followed up for one year after completing treatment, 83% maintained their gains and 17% relapsed. No patients showed symptom substitution. Eighteen percent of the patients receiving imipramine hydrochloride showed marked stimulant side effects on from 5 to 75 mg/day.
Article
• Seventy-six white agoraphobic women, 21 to 45 years old, were treated with combined group exposure in vivo and imipramine or placebo in a randomized double-blind study. A majority of the patients in both the placebo and imipramine groups showed moderate to marked improvement. However, imipramine therapy was significantly superior to placebo therapy on three of the four reported measures of improvement: primary phobia, spontaneous panic, and global improvement. There was a negative correlation between depression and outcome; ie, the more depressed patients fared worse on several outcome measures than those who were less depressed. A comparison of these patients with agoraphobic women previously treated with imipramine and imaginal desensitization showed a superiority of exposure in vivo midway in treatment, but no significant difference between the two groups at the completion of therapy.
Article
• A test-retest reliability study of the Structured Clinical Interview for DSM-III-R was conducted on 592 subjects in four patient and two nonpatient sites in this country as well as one patient site in Germany. For most of the major categories, ks for current and lifetime diagnoses in the patient samples were above.60, with an overall weighted k of.61 for current and.68 for lifetime diagnoses. For the nonpatients, however, agreement was considerably lower, with a mean k of.37 for current and.51 for lifetime diagnoses. These values for the patient and nonpatient samples are roughly comparable to those obtained with other structured diagnostic instruments. Sources of diagnostic disagreement, such as inadequate training of interviewers, information variance, and low base rates for many disorders, are discussed.
Article
To the Editor— Although we welcome discussion of the relative merits of different research criteria for Psy chiatric diagnosis, the article by Drs Overall and Hollister in the Archives (36:1198-1205, 1979) "Comparative Evaluation of Research Diagnostic Criteria for Schizophrenia" troubles us for several reasons. First of all, the authors do not address the issue of the different purposes of various sets of research diagnostic criteria. Whereas the purpose of the actuarial approach taken by Drs Overall and Hollister is to simulate competent or expert clinical practice, the purpose of the Washington University criteria, research diagnostic criteria (RDC), and DSMIII criteria is to improve usual clinical practice by incorporating into the criteria distinctions that have been shown by research study to have some validity in terms of such variables as course, response to specific therapy, familial pattern, etc. Given this difference in purpose, it is hardly adequate to approach the evaluation
Article
this chapter will describe Interpersonal Psychotherapy (IPT) for depression, including the theoretical and empirical bases, efficacy studies, and derivative forms, and will also make recommendations for its use in clinical practice Interpersonal Psychotherapy (IPT) is based on the observation that major depression—regardless of symptom patterns, severity, presumed biological or genetic vulnerability, or the patients' personality traits—usually occurs in an interpersonal context, often an interpersonal loss or dispute / IPT is a brief, weekly psychotherapy that is usually conducted for 12 to 16 weeks, although it has been used for longer periods of time with less frequency as maintenance treatment for recovered depressed patients with major depression / the focus is on improving the quality of the depressed patients' current interpersonal functioning and the problems associated with the onset of depression (PsycINFO Database Record (c) 2012 APA, all rights reserved)
Describes short-term psychodynamic therapy with emphasis on the goals and treatment indications, the time limitations, the setting, the focus, and the analyst–patient relationship. It is suggested that short-term therapy should be considered as the basic form of psychodynamic therapy that can be offered to almost all patients. (26 ref) (PsycINFO Database Record (c) 2012 APA, all rights reserved)
Article
This paper summarizes controlled studies on combined pharmacotherapy (chronic dosage) and psychotherapy in the literature since 1950. Studies purportedly or actually comparing the effects of combined treatment with the effects of either treatment alone are included. Major tranquilizers, minor tranquilizers, group psychotherapy, individual psychotherapy, schizophrenic patients and psychoneurotic patients are relatively well represented, along with single studies dealing with insulin, antidepressants and depressed patients. From a practical point of view, these studies consistently suggest that combined treatment is superior to psychotherapy alone, but not to pharmacotherapy alone. From a theoretical point of view, these studies suggest that the effect of two treatment interventions combined is the same as the effect of the more effective intervention alone. Unfortunately, this point remains highly tentative because of limitations in the design and execution of the available studies. The effect of the psychotherapy offered constitutes a major question in most of the studies reviewed. They suggest that the role of psychotherapy in combined treatment may be clarified in part by including assessments of the effects of psychotherapy alone and pharmacotherapy alone in the designs of future studies. Studies of psychotherapy suggest that the role of psychotherapy in combined treatment may be further clarified by providing contrasting "dosages" of psychotherapy in terms of certain crucial indicators: the therapist's level of experience; the levels of accurate empathy, nonpossessive warmth and genuineness he offers his patients; his score on the Whitehorn-Betz A-B Scale; and the extent to which his interests on the Strong Vocational Interest Blank correspond to those of a reference group of successful psychiatrists. (C) Williams & Wilkins 1969. All Rights Reserved.
Article
The author reviews historical trends, hypotheses, and problems in the application of pharmacotherapy and psychotherapy and uses research findings to develop an integrative model. He portrays a chronology of models over three decades; an "additive" relationship represents the decade of 1970 to 1980. He presents factors that must be considered in determining the effects of pharmacotherapy plus psychotherapy and recommends refinement of these variables in future research.
Die Entwicklung der psychoanalytischen Angst-Konzepte und ihre therapeutischen Folgerungen
  • M Ermann
1892-1899) Über die Berechtigung von der Neurasthenie, einen bestimmten Symptomkomplex als „Angst-Neurose“ abzutrennen. Gesammelte Werke
  • S Freud
A treatment manual for Psychoanalytically Oriented Psychotherapy (POP) Special adaption for Brief Psychotherapy of Anxiety-Prone Patients (POP-B-ANX). Hrsg
  • L Luborsky
Drugs and psychotherapy Handbook of psychotherapy and behavior change
  • Gl Klerman
On transference and countertransference
  • A Balint
  • M Balint
Combining pharmacotherapy and psychotherapy in clinical practice. Spectrum
  • Bd Beitman
  • Gl Klerman
Agoraphobia: Behavioral therapy and pharmacotherapy Combining pharmacotherapy and psychotherapy in clinical practice
  • Mr Mavissakalian
Wenn Therapeuten scheitern: Krisen und Fehlschläge in der psychoanalytischen Psychotherapie
  • C Rhode-Dachser
Psychotherapy of anxiety disorders. Vervielfältigungen aus der Sektion Psychoanalytische Methodik der
  • T E Schacht
  • W P Henry
  • H Strupp
The outcome problem in psychotherapy: Contemporary perspectives
  • H H Strupp
  • HH Strupp
Anxiety and psychodynamic theory Psychiatric update
  • J Nemiah
Psychotherapy in a new key
  • H Strupp
  • J L Binder
Hemmung, Symptom und Angst. Gesammelte Werke, Bd 14
  • S Freud
Research diagnostic criteria: Rationale and reliability
  • Rl Spitzer
  • J Endicott
  • E Robins
Psychotherapie - Einige Bemerkungen zu Forschung, Ausbildung und Praxis
  • H H Strupp
Handbook of psychotherapy and behavior change: An empirical analysis
  • S D Hollon
  • A T Beck
  • SD Hollon
Drugs and psychotherapy
  • G L Klerman
  • GL Klerman
Combining pharmacotherapy and psychotherapy in clinical practice
  • B D Beitman
  • G L Klerman
  • BD Beitman
Special adaption for Brief Psychotherapy of Anxiety-Prone Patients (POP-B-ANX). Hrsg. im Auftrag des SFB 129 „Psychotherapeutische Prozesse“ im PSZ
  • L Luborsky
Combining pharmacotherapy and psychotherapy in clinical practice
  • M R Mavissakalian
  • MR Mavissakalian
Instruction Manual for the Structured Clinical Interview for DSM III (SCID) New York
  • R L Spitzer
  • Jbw Williams
  • RL Spitzer